Trading Symbol
JHS (NSE)
Nature of Disclosure: Regulatory filing submitted to both Bombay Stock Exchange Limited and National Stock Exchange of India Limited intimating about an upcoming board meeting.
Board Meeting Details: The Board of Directors meeting is scheduled to be held on Tuesday, 11th August, 2026. The primary agenda is to consider and approve the Un-Audited Financial Results (both Standalone and Consolidated) for the quarter ended June 30, 2026 (Q1 FY27).
Trading Window Closure: Pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015, the company's trading window has been closed since July 01, 2026 and will remain closed until 48 hours after the announcement of the Un-Audited Financial Results.
Regulatory Compliance: The intimation is made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Additional Information: The disclosure will also be available on the company's website at www.svendgaard.com.
Company Representative: The filing is signed by Komal Jha, Company Secretary and Compliance Officer, on behalf of JHS Svendgaard Laboratories Limited.
Financial Impact: The disclosure does not quantify any financial impact as it serves as advance notice of the board meeting where financial results will be approved.